More frequently, we see technological advancements in wearables that are transforming the healthcare landscape, and our industry partner, Santevation, based in Melbourne, is at the forefront of creating technologies and products designed to restore health and improve longevity.

Collaborating with stakeholders globally in medical devices, hospitals, and universities, Santevation, under the Hub, is working with research teams across UNSW and the University of Sydney on three innovative projects involving flexible pressure sensors, wearable ultrasound devices and biocompatible materials. The projects range from sensor fabrication, characterisation, and product prototyping to sensor arrays for pressure mapping, diagnosis, and developing wearable ultrasound devices.

As technology continues to evolve, the potential for wearables and devices to improve lives is becoming increasingly promising, and Santevation is undoubtedly at the forefront of this exciting frontier. Adding to their innovation, Santevation is proud to have successfully participated in the research and development of infant skincare products under the “Baobei 1000” brand. Our dedication to providing safe and effective products for infants has been a fulfilling journey.

Advancing Infant Skincare: Santevation’s Role in Developing the “Baobei 1000” Brand

The brand name “Baobei 1000” is inspired by Professor David Barker’s DOHaD theory (Developmental Origins of Health and Disease), which emphasises the significant impact of early life environment, nutrition, psychological, and social conditions on an infant’s growth and long-term health. The first 1,000 days of life are particularly crucial in shaping the future of human health.

“Baobei 1000” prioritises safety and effectiveness, recognising that infants have a more delicate skin barrier, necessitating higher standards for ingredient safety. In its initial phase, two product series were developed: a very gentle skincare series designed for newborns aged 0-60 days and a skin protection series specifically for babies aged 0-3 years and above with eczema. Santevation, in collaboration with Huashan Hospital, affiliated with Fudan University and Shanghai First Maternity and Infant Hospital, has empowered the “Baobei 1000” brand from multiple perspectives in China.

Medical experts provided fundamental requirements and design concepts, aiming to create segmented product lines based on the characteristics of newborn and infant skin. They conducted comparative studies on the components of natural and synthetic vernix caseosa, used safer raw materials, and employed lipid encapsulation technology to slowly release moisturising ingredients, extending hydration duration. Based on these insights, Santevation formulated solutions for the synergistic enhancement of raw materials and compound combinations. Our designs utilised a liquid crystal emulsification system and high-quality plant extract complexes to form a protective skin layer while eliminating potentially risky ingredients such as sulphates and benzene compounds, thus enhancing product safety.

Since their launch, the products have received widespread acclaim from medical experts and parents, providing relief to many babies suffering from dry, itchy skin and eczema. For instance, a 2-year-old Chinese baby who had recurrent eczema outbreaks in Canada experienced remarkable improvement after returning to China and using Baobei 1000’s “Subtraction and Addition” product combination, much to the astonishment of her mother.

Additionally, many pregnant women have shown significant interest in the 0-60 days product series. They seek not only to use it for their soon-to-be-born babies but also to benefit themselves during pregnancy, believing that safe bathing and skincare products are crucial during this period.

Santevation is honoured to contribute to this innovative project, and we remain committed to advancing safe, effective skincare solutions for infants and expectant mothers. You can find out more about Santevation and ongoing projects at: www.santevation.com.